SELDI蛋白质芯片检测技术

从基因组学到蛋白质组学,到当前有关小RNA对蛋白质合成调控的研究无一例外地说明蛋白质是直接发挥对生命活动调控的物质。同基因研究相比较,由于蛋白质分子种类繁多,有复杂的修饰成份和空间结构,使得蛋白质研究比较困难。新近发展起来的蛋白质芯片技术为蛋白质的检测和研究提供了新的技术平台,比如荧光标记技术,蛋白质指纹图谱．飞行时间．质谱联用技术（SELDI蛋白质芯片）,表面等离子基元共振生物传感器技术（SPR芯片）以及初步应用的光学蛋白质芯片技术,其中,后三种是新兴的无需标记进行蛋白质检测的技术。就SELDI蛋白质芯片及其新近研究作一综述。     

蛋白质芯片在蛋白质组学研究中的作用

蛋白质芯片是以高度并行性、高通量、微型化和自动化为特点的蛋白质组检测技术。本文综述了蛋白质芯片在蛋白质组学研究中的多种作用,包括普通蛋白质芯片在微量蛋白质分离、蛋白质与蛋白质之间以及蛋白质与其他小分子间相互作用和蛋白质定量检测方面的作用,普通蛋白质芯片通过与质谱技术、生物传感器技术的结合而拓展其应用范围,以及蛋白质组芯片、活性的蛋白质芯片在蛋白质组学研究中应用的进展。     

无细胞系统原位制备蛋白质芯片及其应用

主要介绍了目前在生物芯片表面进行蛋白质无细胞表达与定向制备蛋白质芯片的研究进展,包括各种基因植入芯片的方法、蛋白质体外不同表达的途径、蛋白质固定的策略以及可能的应用发展前景等．蛋白质芯片以其高通量、高灵敏和检测迅速等优点正成为蛋白质组学研究中的重要工具之一．蛋白质的高效表达与纯化、蛋白质在芯片表面的有效固定与蛋白质活性的保持等内容是蛋白质芯片技术发展的关键．采用纳米生物技术与无细胞表达系统,已经可以在生物芯片表面通过植入基因的方式制备相关的蛋白质芯片,从而为蛋白质芯片的原位制备开辟了新的方向．     

蛋白质芯片技术

以前对蛋白质的研究集中在一次研究一种蛋白质 ,通常费时费力 ;而蛋白质芯片技术是研究蛋白质组的新技术 ,是高通量、微型化和自动化的蛋白质分析技术。它可以用来研究蛋白质的亚细胞定位和蛋白质与蛋白质之间的相互作用 ,以及对蛋白质的功能进行生物化学分析 ,将对蛋白质组研究及医学生物学的发展有很大的推动作用。较系统地介绍了蛋白质芯片的概念、制作及检测方法 ;同时也讨论了蛋白质芯片的两种功能形式、存在问题和应用前景。     

无细胞系统原位制备蛋白质芯片片及其应用

主要介绍了目前在生物芯片表面进行蛋白质无细胞表达与定向制备蛋白质芯片的研究进展,包括各种基因植入芯片的方法、蛋白质体外不同表达的途径、蛋白质固定的策略以及可能的应用发展前景等.蛋白质芯片以其高通量、高灵敏和检测迅速等优点正成为蛋白质组学研究中的重要工具之一.蛋白质的高效表达与纯化、蛋白质在芯片表面的有效固定与蛋白质活性的保持等内容是蛋白质芯片技术发展的关键.采用纳米生物技术与无细胞表达系统,已经可以在生物芯片表面通过植入基因的方式制备相关的蛋白质芯片,从而为蛋白质芯片的原位制备开辟了新的方向.     

自组装蛋白质芯片——功能蛋白质组学的新工具

传统的蛋白质芯片制备需要进行繁琐的蛋白质表达与纯化。同时,由于蛋白质活性不稳定,蛋白质芯片不宜长期保存。新一代自组装蛋白质芯片,利用无细胞表达体系和DNA固定技术,能够将蛋白质即时、原位表达并固定在芯片上,有效地解决了传统蛋白质芯片的制备和保存问题。目前自组装蛋白质芯片已初步用于大规模蛋白-蛋白质相互作用的筛选,以及鉴定免疫优势抗原等研究。该文介绍了近年自组装蛋白质芯片技术的进展和应用研究。     

蛋白质芯片在微生物学领域的应用进展

蛋白质芯片是蛋白质组学研究的一种新技术。具有高通量、微型化、连续化、自动化、快速和准确等特点。已成功地应用于蛋白质的鉴定、量化和基础功能及蛋白质组学的研究。在微生物的监测、检测、分离、鉴定分类和微生物资源开发等方面拥有巨大的应用前景。就蛋白质芯片技术及其在微生物领域的应用进展作了概述。     

蛋白质芯片构建技术进展

蛋白质芯片是一项实现蛋白质高通量分析和检测的新型技术,在生命科学的各个领域具有重要的应用前景。但是由于蛋白质本身的敏感性质和芯片的独特结构,蛋白质芯片技术的发展面临许多难点,这些正是蛋白质芯片研究者需要共同讨论的问题。本文从芯片构造、探针的固定方法和检测方法三个方面对芯片的构造进行分析和讨论,并对其相关技术的进展进行综述。     

dsDNA芯片的DNA结合蛋白质计算机模拟系统

dsDNA芯片(double-stranded DNA microarray)是用于DNA结合蛋白质表达研究的新技术,应用一种新的dsDNA芯片制作方法,研究了dsDNA探针设计,开发了相应的计算机模拟系统—DBP软件。可实现芯片上dsDNA探针的选取以及DNA结合蛋白质检测的实验过程模拟,功能包括模拟酶切、模拟电泳、模拟杂交等实验环节。DBP系统包括了可以不断完善的DNA结合蛋白质数据库。对研究dsDNA芯片,检测和分析在生物 体中DNA结合蛋白质的表达谱,揭示细胞的分化和凋亡、信号转导、DNA转录调控的分子机制有重要意义。     

蛋白质芯片

随着人类基因组计划 (ＨＧＰ)顺利实施 ,以生命活动的执行者———蛋白质为研究对象的蛋白质组学越来越显得重要[1] ,并构想和发展了快捷、高效、并行、高通量的蛋白质组检测新技术———蛋白质芯片技术。1.蛋白质芯片的基本构成蛋白质芯片是高通量、微型化和自动化的蛋白质分析技术。目前蛋白质芯片主要分两种[2 ] :一种类似于ＤＮＡ芯片 ,即在固相支持物表面高密度排列的探针蛋白点阵 ,可特异地捕获样品中的靶蛋白 ,然后通过检测器对靶蛋白进行定性或定量分析 (如图1)。另一种就是微型化的凝胶电泳板。在电场作用下 ,样品中的蛋白质通过芯…     

Profiling of cytokine expression by biotin-labeled-based protein arrays

Global analysis of protein expression holds great promise in basic research and patient care. Previously we demonstrated that multiple cytokines could be detected simultaneously using an enzyme-linked immunosorbent assay protein array system with high sensitivity and specificity. In this paper, we described a biotin-labeled-based protein array system to detect multiple cytokines simultaneously from biological samples. In this new approach, proteins from a variety of biological sources are labeled with biotin. The biotin-labeled proteins are then incubated with antibody chips. Targeted proteins are captured by the array antibodies spotted on the antibody chips. The presence of targeted proteins is detected using Cy3- or Cy5-conjugated streptavidin and signals are imaged by laser scanner. The system also can be easily adapted to a two-color binding assay, allowing measurement of the levels of proteins in a test sample with respect to a reference sample at the same chip. To demonstrate its potential applications, we applied this technology to profile human cytokines, chemokines, growth factors, angiogenic factors and proteases in estrogen receptor (ER)+ and ER- cells. These results suggest that biotin-labeled-based antibody chip technology can provide a practical and powerful means of profiling hundreds or thousands of proteins for research and clinical purposes.     

糖芯片研究进展

糖芯片是生物芯片的一种,是继基因芯片、蛋白质芯片、组织芯片等之后发展起来的一种很有前景的生物检测技术。随着糖生物学和糖组学的研究进展,糖芯片正逐步发展为该领域的新型研究手段。介绍了糖芯片技术及其制作方法,高通量分析平台以及糖芯片在生物学研究和医学领域的具体应用,同时也对糖芯片技术的发展进行了展望。     

A consolidated approach to analyzing data from high-throughput protein microarrays with an application to immune response profiling in humans.

Motivation: DNA microarrays are a well-known and established technology in biological and pharmaceutical research providing a wealth of information essential for understanding biological processes and aiding drug development. Protein microarrays are quickly emerging as a follow-up technology, which will also begin to experience rapid growth as the challenges in protein to spot methodologies are overcome. Like DNA microarrays, their protein counterparts produce large amounts of data that must be suitably analyzed in order to yield meaningful information that should eventually lead to novel drug targets and biomarkers. Although the statistical management of DNA microarray data has been well described, there is no available report that offers a successful consolidated approach to the analysis of high-throughput protein microarray data. We describe the novel application of a statistical methodology to analyze the data from an immune response profiling assay using human protein microarray with over 5000 proteins on each chip.     

Analysis of protein interaction and function with a 3-dimensional MALDI-MS protein array

Protein profiling and characterization of protein interactions in biological samples ultimately require indicator-free methods of signal detection, which likewise offer an opportunity to distinguish specific interactions from nonspecific protein binding. Here we describe a new 3-dimensional protein microchip for detecting biomolecular interactions with matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS); the microchip comprises a high-density array of methacrylate polymer elements containing immobilized proteins as capture molecules and directly interfaces with a commercially available mass spectrometer. We demonstrated the performance of the chip in three types of experiments by detecting antibody-antigen interactions, enzymatic activity, and enzyme-inhibitor interactions. MALDI-MS biochip-based tumor necrosisfactor alpha (TNF-alpha) immunoassays demonstrated the feasibility of detecting antigens in complex biological samples by identifying molecular masses of bound proteins even at high nonspecific protein binding. By detecting model interactions of trypsin with trypsin inhibitors, we showed that the protein binding capacity of methacrylate polymer elements and the sensitivity of MALDI-MS detection of proteins bound to these elements surpassed that of other 2- and 3-dimensional substrates tested Immobilized trypsin retained functional (enzymatic) activity within the protein microchip and the specificity of macromolecular interactions even in complex biological samples. We believe that the underlying technology should therefore be extensible to whole-proteome protein expression profiling and interaction mapping.     

SELDI蛋白质芯片检测技术研究进展

从基因组学到蛋白质组学,到当前有关小RNA对蛋白质合成调控的研究无一例外地说明蛋白质是直接发挥对生命活动调控的物质。同基因研究相比较,由于蛋白质分子种类繁多,有复杂的修饰成份和空间结构,使得蛋白质研究比较困难。新近发展起来的蛋白质芯片技术为蛋白质的检测和研究提供了新的技术平台,比如荧光标记技术,蛋白质指纹图谱-飞行时间-质谱联用技术（SELDI蛋白质芯片）,表面等离子基元共振生物传感器技术（SPR芯片）以及初步应用的光学蛋白质芯片技术,其中,后三种是新兴的可无需标记进行蛋白质检测技术。本文就SELDI蛋白质芯片及其新近研究做以综述。     

Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells

The knowledge of signaling pathways that are triggered by physiological and pathological conditions or drug treatment is essential for the comprehension of the biological events that regulate cellular responses. Recently novel platforms based on "reverse-phase protein arrays" have proven to be useful in the study of different pathways, but they still lack the possibility to detect events in the complexity of a cellular context. We developed an "immunocell-array" of cells on chip where, upon cell plating, growing, drug treatment, and fixation, by spotting specific antibodies we can detect the localization and state of hundreds of proteins involved in specific signaling pathways. By applying this technology to mammalian cells we analyzed signaling proteins involved in the response to DNA damage and identified a chromatin remodeling pathway following bleomycin treatment. We propose our technology as a new tool for the array-based multiplexed analysis of signaling pathways in drug response screening, for the proteomics of profiling patient cells, and ultimately for the high throughput screening of antibodies for immunofluorescence applications.     

肿瘤蛋白标志物分析技术研究进展

目前,我国的肿瘤发病率为285.91/10万,平均每分钟有6人被诊断为恶性肿瘤,因此肿瘤的早期诊断的重要性显而易见。随着分子生物学、免疫学诊断技术的飞速发展,寻找肿瘤诊断和预后的特异性标志物已成为近期研究的热点。蛋白质是生命活动中多项功能的执行者,可以直接反映基因给予的信息。相比于基因,蛋白质的表达谱更可以直接地反映功能机制。针对蛋白质的生物特性,本文总结了目前临床中筛查肿瘤蛋白标志物分析技术,如双向凝胶电泳、基质辅助激光解吸/电离-飞行时间质谱、表面增强激光解吸/电离-飞行时间质谱、蛋白质芯片技术,并对未来肿瘤蛋白标志物筛查提出新的展望。     

Effect of antifungal agents on protein composition of Candida albicans studied by capillary electrophoresis and chip technology

In the present study protein profile of a Candida albicans strain had been examined by chip technology and conventional capillary electrophoresis (CE). Profiles could be characterised by the presence of ten dominating protein peaks. These proteins could be distinguished by both techniques, but their quantity showed significant differences in the electropherograms obtained by CE and chip method. Changes in the protein profile were induced by administration of different antifungal agents. Fluconazole and amphotericin B treatment was able to induce similar changes in the pattern, appearance of a 40-kDa protein and up-regulation of a 60-kDa protein was observed by chip technology. Increase in the quantity of these proteins under stress effect (antifungal treatment) might refer to their stress function in the fungal cell. Treatment of C. albicans cells with MK 94 (fused cyclic Mannich ketone) antifungal compound induced not only the previously mentioned changes, but further specific alterations, appearance of a 19-kDa protein and up-regulation of the low molecular weight proteins. This might refer to the different mode of action of this agent on the fungal cells. Conventional capillary electrophoresis was suitable to detect the appearance of the 19-kDa peak, and up-regulation of the 60 kDa protein, but the other changes could not be detected by this technique. Shorter running time, more effective and baseline separation of proteins refer to the advantages of microchip-based method in the analysis of complex biological samples.     

Ligation of expressed protein α-hydrazides via genetic incorporation of an α-hydroxy acid

Expressed protein ligation bridges the gap between synthetic peptides and recombinant proteins and thereby significantly increases the size and complexity of chemically synthesized proteins. Although the intein-based expressed protein ligation method has been extensively used in this regard, the development of new expressed protein ligation methods may improve the flexibility and power of protein semisynthesis. In this study a new alternative version of expressed protein ligation is developed by combining the recently developed technologies of hydrazide-based peptide ligation and genetic code expansion. Compared to the previous intein-based expressed protein ligation method, the new method does not require the use of protein splicing technology and generates recombinant protein α-hydrazides as ligation intermediates that are more chemically stable than protein α-thioesters. Furthermore, the use of an evolved mutant pyrrolysyl-tRNA synthetase(PylRS), ACPK-RS, from M. barkeri shows an improved performance for the expression of recombinant protein backbone oxoesters. By using HdeA as a model protein we demonstrate that the hydrazide-based method can be used to synthesize proteins with correctly folded structures and full biological activity. Because the PylRS-tRNACUAPyl system is compatible with both prokaryotic and eukaryotic cells,the strategy presented here may be readily expanded to manipulate proteins produced in mammalian cells. The new hydrazide-based method may also supplement the intein-based expressed protein ligation method by allowing for a more flexible selection of ligation site.